C.R. Bard Inc. (NYSE:BCR) shares reached a new 52-week high on Monday . The company traded as high as $239.43 and last traded at $237.89, with a volume of 160,484 shares trading hands. The stock had previously closed at $239.00.

BCR has been the topic of a number of research analyst reports. Zacks Investment Research upgraded shares of C.R. Bard from a “hold” rating to a “buy” rating and set a $240.00 target price on the stock in a research note on Friday, April 29th. Leerink Swann boosted their target price on shares of C.R. Bard from $196.00 to $205.00 and gave the company a “market perform” rating in a research note on Wednesday, March 30th. Barclays PLC boosted their target price on shares of C.R. Bard from $212.00 to $224.00 and gave the company an “equal weight” rating in a research note on Tuesday, May 24th. Morgan Stanley reiterated a “hold” rating on shares of C.R. Bard in a research note on Sunday, May 22nd. Finally, Piper Jaffray Cos. reiterated a “buy” rating and issued a $241.00 target price on shares of C.R. Bard in a research note on Tuesday, May 24th. Ten research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $220.13.

The stock has a 50 day moving average price of $227.28 and a 200 day moving average price of $204.64. The firm has a market cap of $17.27 billion and a P/E ratio of 159.28.

C.R. Bard (NYSE:BCR) last announced its quarterly earnings data on Wednesday, April 27th. The company reported $2.34 earnings per share for the quarter, topping analysts’ consensus estimates of $2.17 by $0.17. The firm earned $873.50 million during the quarter, compared to analysts’ expectations of $845.77 million. During the same quarter in the previous year, the firm earned $2.10 earnings per share. C.R. Bard’s revenue was up 6.6% on a year-over-year basis. Analysts expect that C.R. Bard Inc. will post $10.15 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Monday, July 18th will be issued a $0.26 dividend. This is a positive change from C.R. Bard’s previous quarterly dividend of $0.24. The ex-dividend date is Thursday, July 14th. This represents a $1.04 dividend on an annualized basis and a yield of 0.44%.

In related news, CFO Christopher S. Holland sold 3,970 shares of the business’s stock in a transaction that occurred on Friday, May 27th. The shares were sold at an average price of $219.89, for a total value of $872,963.30. Following the completion of the transaction, the chief financial officer now directly owns 31,306 shares in the company, valued at approximately $6,883,876.34. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, VP Sharon M. Luboff sold 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, April 27th. The stock was sold at an average price of $210.00, for a total transaction of $2,100,000.00. Following the completion of the transaction, the vice president now owns 33,706 shares of the company’s stock, valued at $7,078,260. The disclosure for this sale can be found here.

A number of large investors recently made changes to their positions in the stock. Wells Fargo & Company MN raised its stake in shares of C.R. Bard by 1.9% in the fourth quarter. Wells Fargo & Company MN now owns 169,155 shares of the company’s stock worth $32,044,000 after buying an additional 3,132 shares in the last quarter. Hamilton Point Investment Advisors LLC raised its stake in shares of C.R. Bard by 2.8% in the fourth quarter. Hamilton Point Investment Advisors LLC now owns 16,265 shares of the company’s stock worth $3,081,000 after buying an additional 450 shares in the last quarter. Herndon Capital Management LLC bought a new stake in shares of C.R. Bard during the fourth quarter worth $1,428,000. Bank of Montreal Can raised its stake in shares of C.R. Bard by 58.3% in the fourth quarter. Bank of Montreal Can now owns 166,831 shares of the company’s stock worth $31,604,000 after buying an additional 61,469 shares in the last quarter. Finally, Trexquant Investment LP bought a new stake in shares of C.R. Bard during the fourth quarter worth $1,862,000.

C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.